MNKD

FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation’s Investigational Drug to Treat Diabetes

[GlobeNewswire] – VALENCIA, Calif. — MannKind Corporation today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 13 to 1 to recommend that AFREZZA(R) … moreView todays social media effects on MNKDView the latest stocks trending across Twitter. Click to view dashboardSee who MannKind is hiring next, click here to view […]

MannKind’s Upcoming Catalyst(s)

moreView todays social media effects on MNKDView the latest stocks trending across Twitter. Click to view dashboardSee who MannKind is hiring next, click here to view […]

MANNKIND CORP Financials

moreView todays social media effects on MNKDView the latest stocks trending across Twitter. Click to view dashboardSee who MannKind is hiring next, click here to view […]

It’s already a bubble

[at MarketWatch] – Here’s everything a Revolution Investor needs to be reading into the weekend. moreView todays social media effects on MNKDView the latest stocks trending across Twitter. Click to view dashboardSee who MannKind is hiring next, click here to view […]

MannKind’s Management Presents at Cowen and Company 34th Annual Health Care Conference (Transcript)

[at Seeking Alpha] – Simos Simeonidis – Cowen and Company Slide. moreView todays social media effects on MNKDView the latest stocks trending across Twitter. Click to view dashboardSee who MannKind is hiring next, click here to view […]